Hjlm. Ulenkate et al., UP-REGULATION OF B-50 GAP-43 IN SCHWANN-CELLS AT DENERVATED MOTOR END-PLATES AND IN MOTONEURONS AFTER RAT FACIAL-NERVE CRUSH/, Restorative neurology and neuroscience, 6(1), 1993, pp. 35-47
Crush or transection of peripheral nerves of the adult rat is accompan
ied by changes in protein expression, including the growth associated
protein (GAP-43) B-50. Following peripheral nerve crush in rat enhance
d B-50 immunoreactivity was observed in regenerating nerve fibres and
in newly formed axon terminals. However, before reinnervation was appa
rent, an unexpected transient increase in B-50 immunoreactivity was ob
served at denervated motor endplates [J. Neurosci. 8 (1988) 1759]. Thi
s study was performed to clarify this observation. Four days following
facial nerve crush B-50 immunoreactivity was detected by double immun
ofluorescence microscopy in S100-positive Schwann cells covering the d
enervated endplates. Using diluted polyclonal and monoclonal B-50 anti
bodies we found that B-50 immunoreactivity at the denervated motor end
plates was strongly increased in comparison to innervated motor endpla
tes in which B-50 immunoreactivity was hardly detectable. However, whe
n a high concentration of B-50 antibodies was applied the normal inner
vated motor endplates were also B-50 immunoreactive. Muscle fibres did
not display B-50 immunoreactivity. Northern blot analysis revealed el
evated B-50 mRNA in denervated muscle and in degenerating nerve with r
espect to the controls. The B-50 mRNA levels in these non-neuronal tis
sues were very low compared to the intact and injured facial nucleus c
ontaining the neuronal cell bodies. Electron microscopy demonstrated t
hat the B-50 protein was localized in the processes of Schwann cells c
overing axon terminals of intact and vacant motor endplates and in axo
n varicosities of sympathetic nerves. This study has confirmed that pr
ior to reinnervation B-50 immunoreactivity is increased at denervated
motor endplates and shows that B-50 is co-localized with S100 in Schwa
nn cells. Therefore, upregulation of B-50 expression in Schwann cells
may explain the early occurrence of B-50 immunoreactivity at the motor
endplate.